ID   EBNA6_EBVB9             Reviewed;         992 AA.
AC   P03204; Q777E7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   07-APR-2021, entry version 114.
DE   RecName: Full=Epstein-Barr nuclear antigen 6;
DE            Short=EBNA-6;
DE            Short=EBV nuclear antigen 6;
DE   AltName: Full=Epstein-Barr nuclear antigen 3C;
DE            Short=EBNA-3C;
DE            Short=EBV nuclear antigen 3C;
DE   AltName: Full=Epstein-Barr nuclear antigen 4B;
DE            Short=EBNA-4B;
DE            Short=EBV nuclear antigen 4B;
GN   Name=EBNA6; ORFNames=BERF3-BERF4;
OS   Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4).
OC   Viruses; Duplodnaviria; Heunggongvirae; Peploviricota; Herviviricetes;
OC   Herpesvirales; Herpesviridae; Gammaherpesvirinae; Lymphocryptovirus.
OX   NCBI_TaxID=10377;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=6087149; DOI=10.1038/310207a0;
RA   Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J.,
RA   Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C.,
RA   Tuffnell P.S., Barrell B.G.;
RT   "DNA sequence and expression of the B95-8 Epstein-Barr virus genome.";
RL   Nature 310:207-211(1984).
RN   [2]
RP   CHARACTERIZATION.
RX   PubMed=2831394; DOI=10.1128/jvi.62.4.1330-1338.1988;
RA   Petti L., Sample J., Wang F., Kieff E.;
RT   "A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in
RT   latently infected growth-transformed lymphocytes.";
RL   J. Virol. 62:1330-1338(1988).
RN   [3]
RP   INTERACTION WITH HUMAN RBPJ.
RX   PubMed=8627785; DOI=10.1128/jvi.70.5.3068-3074.1996;
RA   Robertson E.S., Lin J., Kieff E.;
RT   "The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B,
RT   and 3C interact with RBPJ(kappa).";
RL   J. Virol. 70:3068-3074(1996).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=2161150; DOI=10.1016/0042-6822(90)90027-o;
RA   Petti L., Sample C., Kieff E.;
RT   "Subnuclear localization and phosphorylation of Epstein-Barr virus latent
RT   infection nuclear proteins.";
RL   Virology 176:563-574(1990).
RN   [5]
RP   INTERACTION WITH HUMAN CTBP1.
RX   PubMed=11462050; DOI=10.1128/jvi.75.16.7749-7755.2001;
RA   Touitou R., Hickabottom M., Parker G., Crook T., Allday M.J.;
RT   "Physical and functional interactions between the corepressor CtBP and the
RT   Epstein-Barr virus nuclear antigen EBNA3C.";
RL   J. Virol. 75:7749-7755(2001).
RN   [6]
RP   FUNCTION.
RX   PubMed=16352731; DOI=10.1073/pnas.0503886102;
RA   Knight J.S., Sharma N., Robertson E.S.;
RT   "Epstein-Barr virus latent antigen 3C can mediate the degradation of the
RT   retinoblastoma protein through an SCF cellular ubiquitin ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:18562-18566(2005).
RN   [7]
RP   INTERACTION WITH HUMAN MYC.
RX   PubMed=18256156; DOI=10.1128/jvi.02500-07;
RA   Bajaj B.G., Murakami M., Cai Q., Verma S.C., Lan K., Robertson E.S.;
RT   "Epstein-Barr virus nuclear antigen 3C interacts with and enhances the
RT   stability of the c-Myc oncoprotein.";
RL   J. Virol. 82:4082-4090(2008).
RN   [8]
RP   INTERACTION WITH HOST HISTONE H2AX, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=24429368; DOI=10.1128/jvi.03568-13;
RA   Jha H.C., Aj M.P., Saha A., Banerjee S., Lu J., Robertson E.S.;
RT   "Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.";
RL   J. Virol. 88:3776-3788(2014).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25121590; DOI=10.1371/journal.ppat.1004304;
RA   Banerjee S., Lu J., Cai Q., Sun Z., Jha H.C., Robertson E.S.;
RT   "EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to
RT   promote B-cell proliferation.";
RL   PLoS Pathog. 10:E1004304-E1004304(2014).
RN   [10]
RP   INTERACTION WITH HOST TP73, AND SUBCELLULAR LOCATION.
RX   PubMed=24314664; DOI=10.1016/j.virol.2013.10.023;
RA   Sahu S.K., Mohanty S., Kumar A., Kundu C.N., Verma S.C., Choudhuri T.;
RT   "Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between
RT   a viral oncoprotein and cellular tumor suppressor.";
RL   Virology 448:333-343(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 258-266.
RX   PubMed=15657948; DOI=10.1002/eji.200425724;
RA   Stewart-Jones G.B., di Gleria K., Kollnberger S., McMichael A.J.,
RA   Jones E.Y., Bowness P.;
RT   "Crystal structures and KIR3DL1 recognition of three immunodominant viral
RT   peptides complexed to HLA-B*2705.";
RL   Eur. J. Immunol. 35:341-351(2005).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 281-290.
RX   PubMed=19139173; DOI=10.1084/jem.20082136;
RA   Archbold J.K., Macdonald W.A., Gras S., Ely L.K., Miles J.J., Bell M.J.,
RA   Brennan R.M., Beddoe T., Wilce M.C., Clements C.S., Purcell A.W.,
RA   McCluskey J., Burrows S.R., Rossjohn J.;
RT   "Natural micropolymorphism in human leukocyte antigens provides a basis for
RT   genetic control of antigen recognition.";
RL   J. Exp. Med. 206:209-219(2009).
CC   -!- FUNCTION: Plays an essential role for the activation and
CC       immortalization of human B-cells. Represses transcription of viral
CC       promoters TP1 and Cp through interaction with host RBPJ, and inhibits
CC       EBNA2-mediated activation of these promoters. Since Cp is the promoter
CC       for all EBNA mRNAs, EBNA6 probably contributes to a negative
CC       autoregulatory control loop. Alternatively, EBNA6 also regulates the
CC       transcription of the EBV oncogene LMP1 in a cell cycle-dependent
CC       manner. Modulates the activity of several host proteins involved in
CC       cell cycle regulation including host cyclin A, MYC, RB, p21 and p27
CC       mainly through binding to the host SCF(SKP2) complex. Inhibits the
CC       promoter of host H2AX and targets H2AX to proteasomal degradation in
CC       order to promote latency and cell proliferation.
CC       {ECO:0000269|PubMed:16352731, ECO:0000269|PubMed:24429368,
CC       ECO:0000269|PubMed:25121590}.
CC   -!- SUBUNIT: Interacts with host CTPB1; this interaction seems important
CC       for EBNA6-mediated transcriptional repression. Interacts with host MYC;
CC       this interaction enhances MYC stability. Interacts (via N-terminus)
CC       with host RBPJ. Interacts (via N-terminus) with host histone H2AX; this
CC       interaction facilitates H2AX proteasomal degradation. Interacts with
CC       host TP73; this interaction inhibits TP73-mediated apoptotic pathway.
CC       {ECO:0000269|PubMed:11462050, ECO:0000269|PubMed:18256156,
CC       ECO:0000269|PubMed:24314664, ECO:0000269|PubMed:24429368,
CC       ECO:0000269|PubMed:8627785}.
CC   -!- INTERACTION:
CC       P03204; Q9Y676: MRPS18B; Xeno; NbExp=6; IntAct=EBI-9255985, EBI-750085;
CC       P03204; P01106: MYC; Xeno; NbExp=11; IntAct=EBI-9255985, EBI-447544;
CC       P03204; Q06330: RBPJ; Xeno; NbExp=3; IntAct=EBI-9255985, EBI-632552;
CC   -!- SUBCELLULAR LOCATION: Host nucleus {ECO:0000269|PubMed:24314664,
CC       ECO:0000269|PubMed:24429368, ECO:0000269|PubMed:25121590}. Host nucleus
CC       matrix {ECO:0000269|PubMed:2161150}. Note=Associated with the nuclear
CC       matrix.
CC   -!- SIMILARITY: Belongs to the herpesviridae EBNA-6 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; V01555; CAA24859.1; -; Genomic_DNA.
DR   EMBL; AJ507799; CAD53421.1; -; Genomic_DNA.
DR   RefSeq; YP_401671.1; NC_007605.1.
DR   PDB; 1CG9; X-ray; 2.70 A; C=98-106.
DR   PDB; 2BSR; X-ray; 2.30 A; C=258-266.
DR   PDB; 3DX6; X-ray; 1.70 A; C=281-290.
DR   PDB; 3DX7; X-ray; 1.60 A; C=281-290.
DR   PDB; 3DX8; X-ray; 2.10 A; C=281-290.
DR   PDB; 3DXA; X-ray; 3.50 A; C/H/M=281-290.
DR   PDBsum; 1CG9; -.
DR   PDBsum; 2BSR; -.
DR   PDBsum; 3DX6; -.
DR   PDBsum; 3DX7; -.
DR   PDBsum; 3DX8; -.
DR   PDBsum; 3DXA; -.
DR   SMR; P03204; -.
DR   BioGRID; 3509134; 3.
DR   DIP; DIP-29893N; -.
DR   ELM; P03204; -.
DR   IntAct; P03204; 7.
DR   MINT; P03204; -.
DR   GeneID; 3783763; -.
DR   KEGG; vg:3783763; -.
DR   EvolutionaryTrace; P03204; -.
DR   Proteomes; UP000153037; Genome.
DR   GO; GO:0044204; C:host cell nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0039526; P:modulation by virus of host apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0039645; P:modulation by virus of host G1/S transition checkpoint; IEA:UniProtKB-KW.
DR   GO; GO:0019042; P:viral latency; IEA:UniProtKB-KW.
DR   InterPro; IPR007706; EBNA-3/4/6.
DR   Pfam; PF05009; EBV-NA3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; G1/S host cell cycle checkpoint dysregulation by virus;
KW   Host nucleus; Host-virus interaction;
KW   Modulation of host cell apoptosis by virus;
KW   Modulation of host cell cycle by virus; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Viral latency;
KW   Viral latency initiation and maintenance.
FT   CHAIN           1..992
FT                   /note="Epstein-Barr nuclear antigen 6"
FT                   /id="PRO_0000116179"
FT   REPEAT          551..555
FT                   /note="1-1; approximate"
FT   REPEAT          556..560
FT                   /note="2-1; approximate"
FT   REPEAT          561..565
FT                   /note="3-1; approximate"
FT   REPEAT          566..570
FT                   /note="4-1"
FT   REPEAT          571..575
FT                   /note="5-1"
FT   REPEAT          576..580
FT                   /note="6-1"
FT   REPEAT          581..585
FT                   /note="7-1"
FT   REPEAT          586..590
FT                   /note="8-1"
FT   REPEAT          591..595
FT                   /note="9-1"
FT   REPEAT          596..600
FT                   /note="10-1; approximate"
FT   REPEAT          601..605
FT                   /note="11-1; approximate"
FT   REPEAT          606..610
FT                   /note="12-1"
FT   REPEAT          741..753
FT                   /note="1-2"
FT   REPEAT          754..766
FT                   /note="2-2"
FT   REPEAT          767..779
FT                   /note="3-2"
FT   REGION          551..610
FT                   /note="12 X 5 AA approximate tandem repeats of P-P-A-A-G"
FT   REGION          741..779
FT                   /note="3 X 13 AA tandem repeats of P-[AP]-P-Q-A-P-Y-Q-G-Y-
FT                   Q-E-P"
FT   COMPBIAS        74..80
FT                   /note="Poly-Arg"
SQ   SEQUENCE   992 AA;  109129 MW;  39BEAB9BC515BD84 CRC64;
     MESFEGQGDS RQSPDNERGD NVQTTGEHDQ DPGPGPPSSG ASERLVPEES YSRDQQPWGQ
     SRGDENRGWM QRIRRRRRRR AALSGHLLDT EDNVPPWLPP HDITPYTARN IRDAACRAVK
     QSHLQALSNL ILDSGLDTQH ILCFVMAARQ RLQDIRRGPL VAEGGVGWRH WLLTSPSQSW
     PMGYRTATLR TLTPVPNRVG ADSIMLTATF GCQNAARTLN TFSATVWTPP HAGPREQERY
     AREAEVRFLR GKWQRRYRRI YDLIELCGSL HHIWQNLLQT EENLLDFVRF MGVMSSCNNP
     AVNYWFHKTI GNFKPYYPWN APPNENPYHA RRGIKEHVIQ NAFRKAQIQG LSMLATGGEP
     RGDATSETSS DEDTGRQGSD VELESSDDEL PYIDPNMEPV QQRPVMFVSR VPAKKPRKLP
     WPTPKTHPVK RTNVKTSDRS DKAEAQSTPE RPGPSEQSSV TVEPAHPTPV EMPMVILHQP
     PPVPKPVPVK PTPPPSRRRR GACVVYDDDV IEVIDVETTE DSSSVSQPNK PHRKHQDGFQ
     RSGRRQKRAA PPTVSPSDTG PPAVGPPAAG PPAAGPPAAG PPAAGPPAAG PPAAGPRILA
     PLSAGPPAAG PHIVTPPSAR PRIMAPPVVR MFMRERQLPQ STGRKPQCFW EMRAGREITQ
     MQQEPSSHLQ SATQPTTPRP SWAPSVCALS VMDAGKAQPI ESSHLSSMSP TQPISHEEQP
     RYEDPDAPLD LSLHPDVAAQ PAPQAPYQGY QEPPAPQAPY QGYQEPPPPQ APYQGYQEPP
     AHGLQSSSYP GYAGPWTPRS QHPCYRHPWA PWSQDPVHGH TQGPWDPRAP HLPPQWDGSA
     GHGQDQVSQF PHLQSETGPP RLQLSLVPLV SSSAPSWSSP QPRAPIRPIP TRFPPPPMPL
     QDSMAVGCDS SGTACPSMPF ASDYSQGAFT PLDINATTPK RPRVEESSHG PARCSQATAE
     AQEILSDNSE ISVFPKDAKQ TDYDASTESE LD
//
